Statistics for Vanda Pharmaceuticals (id:6596 VNDA)

Valuation metrics

Market cap

290.37M

Enterprise value

-76,780,280.00

Trailing P/E (ttm)

126.00

Forward P/E

24.90

PEG ratio

24.90

Price/Sales (ttm)

1.52

Price/Book (mrq)

0.54

Enterprise Value/Revenue

-0.40

Enterprise Value/EBITDA

2.55

Overview

Shares outstanding

58.31M

Float

52.53M

Shares short

3.74M

% Held by insiders

0.03%

% Held by institutions

0.78%

Average volume (10 days)

852.74K

Average volume (90 days)

Price summary

52-Week low

3.46

52-Week high

6.75

52-Week change

30.06%

Beta

0.77

50-Day moving average

4.80

200-Day moving average

4.95

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-8.59%

Operating margin

-23.08%

Operational effectiveness

Return on assets

-3.64%

Return on equity

-3.02%

Income statement

Revenue (ttm)

3.29

Revenue per share (ttm)

3.29

Quarterly revenue growth (yoy)

Gross profit (ttm)

177.84M

EBITDA

-30,158,000.00

Net income to common (ttm)

-16,388,000.00

Diluted EPS (ttm)

-0.29

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

376.26M

Total cash per share (mrq)

6.45

Total debt (mrq)

7.94M

Total Debt/Equity (mrq)

1.47

Current ratio (mrq)

485.30%

Book value per share (mrq)

9.28

Cash flow

Cash flow statement

-17,672,000.00

Levered free cash flow (LFCF)

-114,488,000.00